Gene function identified in type 1 diabetes progression

by Kerry Faulkner
The pancreas: type 1 diabetes is caused when the pancreas fails to produce enough insulin because the necessary beta-cells have been destroyed by the body’s immune system. Credit: Rafael Mondini

IDENTIFYING a genetic weakness that causes type 1 diabetes in children has opened the way for development of a treatment capable of preventing the disease.

The genetic weakness has been pinpointed by researchers at Perth's Harry Perkins Institute of Medical Research working as part of a global consortium, who studied the mechanisms for the gene cathepsin H (CTSH) to influence in the pancreas of type 1 diabetics.

Type 1 diabetes is caused when the pancreas fails to produce enough insulin because the necessary beta-cells have been destroyed by the body's immune system.

The research shows CTSH may affect disease progression by modulating the survival and function of which are the target of autoimmune assault.

However, the exact way CTSH works in beta-cells has not been determined— of CTSH has been found to be beneficial but a weakness in the CTSH gene can make cells more vulnerable to an .

The Institute's Grant Morahan says the research investigated over 200 blood samples at the gene's RNA and protein levels from patients worldwide, to see how changed.

"Our results showed the CTSH gene was active but we had to go to the next step and show that RNA was translated into protein—that was really dotting the 'I's and crossing the 'T's," Prof Morahan says.

"Type 1 diabetes is due to the insulin producing beta-cells being destroyed by an autoimmune response and this particular variant in the CTSH gene makes those cells more vulnerable to attack from the immune system.

"This is crucial, because now we know the exact molecular weakness in beta cells."

CTSH gene presence also protects beta-cells

The WA team's Danish collaborators showed higher levels of the CTSH gene protected the body's antibody-producing beta-cells from dying when attacked by the immune system. Those people with higher levels had better cell function and slower progression to .

Professor Morahan says proving this protective capability means it is possible to develop drugs either to increase production of the gene in beta-cells, or to mimic the function of CTSH in beta cells and prevent the disease.

"We should now try and find some way of blocking the biochemical pathway to cell death that the CTSH molecule participates in, so that's what people will be looking at in the next stage," he says.

"Type 1 diabetes affects children and they have it for the rest of their lives so the goal of our research is to come up with a way to prevent children from getting ."

More information: "CTSH regulates β-cell function and disease progression in newly diagnosed type 1 diabetes patients." Tina Fløyel, et al. PNAS DOI: 10.1073/pnas.1402571111

add to favorites email to friend print save as pdf

Related Stories

Loss of function of a single gene linked to diabetes in mice

Jan 04, 2014

Researchers from the University of Illinois at Chicago College of Medicine have found that dysfunction in a single gene in mice causes fasting hyperglycemia, one of the major symptoms of type 2 diabetes. Their findings were ...

Researchers find new pathway connected to type 2 diabetes

Mar 19, 2014

Scientists at the Children's Hospital of Eastern Ontario (CHEO) Research Institute have discovered a cellular pathway that is responsible for keeping blood sugar levels low in obese or pre-diabetic people, and may prevent ...

Recommended for you

Infant cooing, babbling linked to hearing ability

5 hours ago

Infants' vocalizations throughout the first year follow a set of predictable steps from crying and cooing to forming syllables and first words. However, previous research had not addressed how the amount ...

Developing 'tissue chip' to screen neurological toxins

6 hours ago

A multidisciplinary team at the University of Wisconsin-Madison and the Morgridge Institute for Research is creating a faster, more affordable way to screen for neural toxins, helping flag chemicals that ...

Gene mutation discovered in blood disorder

10 hours ago

An international team of scientists has identified a gene mutation that causes aplastic anemia, a serious blood disorder in which the bone marrow fails to produce normal amounts of blood cells. Studying a family in which ...

Airway muscle-on-a-chip mimics asthma

12 hours ago

The majority of drugs used to treat asthma today are the same ones that were used 50 years ago. New drugs are urgently needed to treat this chronic respiratory disease, which causes nearly 25 million people ...

User comments